Items Tagged ‘#Lymph2Cx test’
December 21, 2016
Mayo Clinic first in U.S. to offer lymphoma genomic diagnostic test for patients
By Sharon Rosen 
Article by Colette Gallagher, Public Affairs More than 20,000 people in the U.S. are diagnosed with diffuse large B-cell lymphoma, the most common type of non-Hodgkin’s lymphoma each year. Mayo Clinic is the first site in the country to offer a genetic test to help guide diagnosis and treatment of patients with diffuse large B-cell […]
Tags: #diffuse large B cell lymphoma, #Lymph2Cx test, #Mayo Clinic Molecular Diagnostic Arizona Laboratory, #non-Hodgkin's lymphoma, center for individualized medicine, lymphoma, mayo clinic, medical research, Precision Medicine